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Protrudin functions from the endoplasmic
reticulum to support axon regeneration in the adult
CNS
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Adult mammalian central nervous system axons have intrinsically poor regenerative capacity,
so axonal injury has permanent consequences. One approach to enhancing regeneration is to
increase the axonal supply of growth molecules and organelles. We achieved this by
expressing the adaptor molecule Protrudin which is normally found at low levels in non-
regenerative neurons. Elevated Protrudin expression enabled robust central nervous system
regeneration both in vitro in primary cortical neurons and in vivo in the injured adult optic
nerve. Protrudin overexpression facilitated the accumulation of endoplasmic reticulum,
integrins and Rab11 endosomes in the distal axon, whilst removing Protrudin’s endoplasmic
reticulum localization, kinesin-binding or phosphoinositide-binding properties abrogated the
regenerative effects. These results demonstrate that Protrudin promotes regeneration by
functioning as a scaffold to link axonal organelles, motors and membranes, establishing
important roles for these cellular components in mediating regeneration in the adult central
nervous system.
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Axons of immature central nervous system (CNS) and adultperipheral nervous system (PNS) neurons readily regen-erate after injury1,2. In contrast, adult CNS neurons lose
their regenerative ability with maturation3, meaning that axonal
injury or disease has life-altering consequences and that there is
little chance of recovery. In addition to the non-permissive
extracellular environment after injury, intrinsic neuronal factors
also play an important role in the regenerative failure observed in
mature CNS neurons4,5. Studies aimed at enhancing CNS
regeneration have identified transcriptional and epigenetic pro-
grams6,7, signalling pathways8–10, the cytoskeleton11–14 and axon
transport15–19 as important factors governing regenerative ability.
However, the precise machinery required to reconstitute and
extend an injured axon is not completely understood, and
repairing the injured CNS remains a challenging objective20.
This study focuses on the adaptor molecule Protrudin as a tool
for investigating and enhancing axon growth and regeneration in
the adult CNS. Protrudin is an integral endoplasmic reticulum
(ER) membrane protein that has two properties which make it a
candidate for enabling axon regeneration. First, overexpression of
Protrudin causes protrusion formation in non-neuronal cell lines,
and promotes neurite outgrowth in neuronal cells21; second,
Protrudin is a scaffolding molecule which possesses interaction
sites for key axon growth-related molecules and structures21.
Through its Rab11 and kinesin-1 (KIF5) binding sites, Protrudin
can enable the anterograde transport of Rab11-positive recycling
endosomes, leading to their and their cargo’s accumulation at
protrusion tips21,22. This is relevant to CNS axon repair because
increased Rab11 transport into CNS axons in vitro increases their
regenerative ability19.
Protrudin localizes to the ER through two transmembrane
domains and a hairpin loop and interacts with VAP proteins at
ER-membrane contact sites through an FFAT domain. This
interaction is involved in its effects on protrusion outgrowth23–25.
In addition to its localization at ER tubules, Protrudin also reg-
ulates ER distribution and network formation23. Protrudin also
has a FYVE domain that binds to phosphoinositides enabling
interaction with endosomes and the surface membrane25. Specific
phosphoinositides are required at the growth cone during rapid
axon growth and for axon regeneration26. Protrudin therefore
links a number of cellular components associated with axonal
growth. Our hypothesis was that the expression of an active form
of Protrudin would enable regeneration of CNS axons via a
combination of these interactions and would be a powerful tool
for understanding the mechanisms of axon regeneration.
Our initial studies found that Protrudin mRNA is expressed at
low levels in CNS neurons, but at higher levels in regenerating
PNS neurons, and the protein is present in immature regenerative
CNS axons but is depleted from axons with maturity as regen-
eration is lost. We reasoned that overexpression might allow for
increased availability of regenerative machinery within the axon,
leading to better regeneration after injury. Because stimulation of
protrusions through the interaction of Protrudin and Rab11 is
increased by growth factor receptor phosphorylation, and its
protrusive effects are prevented by dominant-negative mutations
of the ERK phosphorylation sites, we created a phosphomimetic,
active form of Protrudin, mutating these previously identified
phosphorylation sites21.
Here, we report that Protrudin promotes axon regeneration
through the mobilization of endosomes and ER into the distal
part of injured axons, whilst having striking effects on neuronal
survival after axotomy. Importantly, Protrudin expression only
has moderate effects on developmental axon growth but has
strong effects on regeneration. Overexpression of Protrudin,
particularly in its phosphomimetic form, led to robust regen-
eration and neuroprotection of mature cortical axons in vitro and
of retinal ganglion cell (RGC) axons in the injured optic nerve.
Protrudin expression caused increased transport of Rab11
endosomes, integrins, and an accumulation of ER in the axon tip,
with phosphomimetic Protrudin increasing this effect. Deleting
either the ER transmembrane domains or VAP-binding FFAT
domain prevented the accumulation of the ER whilst also abro-
gating the effects on regeneration. Interfering with other key
domains of Protrudin also eliminated the regenerative effects,
indicating that Protrudin promotes regeneration by acting as a
scaffold in the axonal ER, bringing together growth components,
organelles and membranes to enable CNS axon regeneration.
Results
Protrudin has several key domains, including a Rab11-binding
domain (RBD), three hydrophobic membrane-association domains
(TM 1–3), an FFAT motif for binding to VAP proteins at ER
contact sites, a coiled-coiled (CC) domain (which interacts
with kinesin 1) and a phosphoinositide-binding FYVE domain
which enables interaction with endosomes and the plasma
membrane21,23–25,27. The map of these domains is shown in Fig. 1a.
Figure 1b shows the phosphorylation sites that were mutated to
produce phosphomimetic Protrudin in accordance with the pre-
vious literature21. We tested the ability of wild-type and phospho-
mimetic Protrudin to induce protrusion formation in HeLa cells as
previously described as a distinctive feature of Protrudin21. We
found that both wild-type and phosphomimetic Protrudin stimulate
protrusion formation compared to cells expressing a control con-
struct (Supplementary Fig. 1a, b). Cells overexpressing phospho-
mimetic Protrudin showed a higher percentage of protrusion
formation as well as longer protrusions compared to wild-type
Protrudin confirming the active phenotype of our phosphomimetic
form of the protein (Supplementary Fig. 1a–c).
Protrudin is expressed at low levels in mature, non-
regenerative CNS neurons. In order to affect growth and
regeneration, we reasoned that Protrudin would need to be pre-
sent in axons in a significant quantity and be optimally func-
tional. We first examined the mRNA expression of Protrudin in
developing CNS and PNS neurons, as well in PNS neurons after
injury, using previously published RNA-sequencing datasets. We
found that Protrudin mRNA (Zfyve27) is expressed at low levels
in CNS neurons, and its expression is not developmentally
regulated (Fig. 1c)19. In contrast, in sensory, regeneration-capable
neurons, the Protrudin transcript increases with development,
during axon growth in vitro, and in response to peripheral nerve
injury (Fig. 1d)28.
To assess the level and distribution of Protrudin protein in CNS
axons, we examined its endogenous localization in rat primary
cortical neurons by immunocytochemistry. We compared devel-
oping neurons (2–4 days after plating at E18), with mature neurons
that have lost the ability to regenerate their axons (matured in vitro
for 14+ days). We found that Protrudin localized to both axons and
dendrites of developing cortical neurons but was enriched in
dendrites and restricted from axons at later stages, coinciding with
the time when cortical neurons mature and lose their regenerative
ability (Fig. 1e, f)19. By measuring the axon and dendrite
fluorescence intensity of Protrudin immunolabelling we found that
younger neurons (2–4 days in vitro, DIV) had a higher axon-to-
dendrite ratio (ratio= 1) compared with later stages of develop-
ment (7–9 DIV, ratio= 0.47 and 14–16 DIV, ratio= 0.44) (Fig. 1g).
These observations suggest that endogenous Protrudin may not be
present in sufficient quantity in mature CNS axons to influence
regeneration. Overexpression of either wild-type or phosphomi-
metic Protrudin resulted in a substantial increase in the protein
level in rat primary cortical neurons (Supplementary Fig. 2). This
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resulted in an increased axon-to dendrite ratio in neurons
overexpressing wild-type (ratio= 0.77) or phosphomimetic
(ratio= 0.78) Protrudin at 14–16 DIV indicating an increase in
the protein’s distribution to axons, with Protrudin easily detectable
throughout axons (Fig. 1f, g). The exclusion of Protrudin from
mature axons is therefore not absolute and can be overcome by
overexpression. Overexpression of Protrudin had no effect on soma
size or spine number and morphology whilst phosphomimetic
Protrudin had a modest effect on increasing dendritic tree
complexity (Supplementary Fig. 3).
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Overexpression of wild-type or phosphomimetic Protrudin
enhances axon regeneration in vitro. Protrudin overexpression
has previously been associated with enhanced neurite outgrowth
in HeLa and PC12 cells as well as primary hippocampal neurons
at early stages of development21. Given that Protrudin is
expressed at low levels in CNS neurons, we reasoned that its
overexpression might increase axon growth. We transfected wild-
type or phosphomimetic Protrudin into immature 2 DIV cortical
neurons and measured the growth of axons and dendrites at 4
DIV (Fig. 2a). Overexpression of phosphomimetic Protrudin had
a modest effect on this early phase of axon growth, with neurons
overexpressing phosphomimetic Protrudin having increased
length of the longest neurite (580 µm) compared to control-
transfected neurons (470 µm) (Fig. 2b). Overexpression of wild-
type Protrudin had no effect. These results show that high levels
of phosphomimetic Protrudin have a small effect on the initial
outgrowth phase of neurons in culture. At this time axon growth
is already rapid (i.e. axons usually regenerate when cut), and the
maturation-related compartmentalization of the neurons to
exclude growth-related molecules from axons has not yet
occurred19.
We next examined the effect of Protrudin overexpression on
axon regeneration in mature axons. We used the laser axotomy
model of regenerative decline, where axons progressively lose
their regenerative ability as they mature and become electrically
active (Fig. 2c)18,19. Cortical neurons were again transfected with
either control, wild-type or phosphomimetic Protrudin, this time
at 10 DIV. We examined axon regeneration after laser injury at
13–17 DIV, when regenerative capacity has declined19. In this
model, axons typically show two responses to injury, either the
formation of a retraction bulb and no regeneration, or retraction
and bulb formation followed by growth cone development and
axon extension (Fig. 2d). Expression of either wild-type or
phosphomimetic Protrudin led to a dramatic increase in the
percentage of axons regenerating after laser axotomy (Fig. 2e,
Supplementary Video 1) with axons regenerating longer distances
(Fig. 2f) and initiating regeneration in a shorter time (Fig. 2g).
The speed of axon extension after growth cone initiation did not
differ between the three conditions (Fig. 2h). This indicates that
Protrudin has its most pronounced effect on initial growth cone
formation, rather than on the axon elongation phase of
regeneration. These regenerative events were most pronounced
in neurons transfected with phosphomimetic Protrudin. Impor-
tantly, overexpressed wild-type and phosphomimetic Protrudin
was found to localize throughout axons, accumulating at the
growth cones of uninjured axons, at regenerating growth cones,
and at the retraction bulbs of non-regenerating injured axons. At
the growth cone, Protrudin localized principally to the central
domain (Supplementary Fig. 4d–f).
Protrudin’s effect on axon regeneration was dose dependent;
co-transfection with a construct encoding GFP resulted in lower
Protrudin expression and a reduced effect on regeneration
(Supplementary Fig. 4a–c). These results show that Protrudin,
particularly in its constitutively active phosphomimetic form, has
a very strong effect on the rescue of axon regeneration in mature
neurons. There is therefore a contrast between Protrudin’s minor
enhancement of the outgrowth of immature axons that are
already growing rapidly, and the rescue of regeneration in mature
neurons whose axons seldom regenerate.
Protrudin promotes regeneration through increased endoso-
mal transport. Protrudin has several interaction sites that have
the potential to link endosomes, ER, membrane and kinesin. Our
hypothesis, based on studies of how Protrudin causes neurite
growth in HeLa and PC12 cells21 and our studies of Rab11
vesicles and their cargo in regeneration19, was that the main effect
of Protrudin would be to enable transport of Rab11 vesicles and
their contents into mature axons through linkage to KIF5, so
increasing regenerative capacity. In order to determine if Pro-
trudin’s regenerative effects were mediated through enhanced
axonal transport, we examined the transport of Rab11 in the
presence of wild-type or phosphomimetic Protrudin, and also
studied the transport of a known Rab11 cargo, integrin alpha 929.
This integrin can mediate long-range sensory regeneration in the
spinal cord15. In addition, we overexpressed three mutated Pro-
trudin constructs targeting domains associated with endosomal
transport (Rab-binding domain, KIF5-interaction domain, and
FYVE domain), and examined axon regeneration after laser
axotomy.
To determine whether Protrudin’s regenerative effects were
also accompanied by an increase in axonal transport, we used
spinning-disc live-cell microscopy to observe the movement of
Rab11-GFP or integrin α9-GFP in the distal part of mature,
13–17 DIV axons in the presence of overexpressed wild-type or
phosphomimetic Protrudin (Fig. 3a). Vesicle transport was scored
as anterograde, retrograde, bidirectional or static and the total
number of Rab11 or integrin α9-positive endosomes per section
of axon was measured. The majority of Rab11-positive vesicles
trafficked bidirectionally whereas the bulk of integrin-containing
endosomes moved retrogradely confirming previous studies18,29.
Overexpression of either wild-type or phosphomimetic Protrudin
resulted in increased retrograde and bidirectional transport of
Rab11-GFP and enhanced anterograde and retrograde transport
of integrin α9-GFP (Fig. 3b–d), leading to more total Rab11 and
integrin-positive vesicles in the distal axon (Fig. 3b–d). The
finding that phosphomimetic Protrudin has no additional effect
on axonal transport compared with wild-type Protrudin suggests
that phospho-mimetic Protrudin does not function to further
stimulate Rab11 transport. Approximately 20% of α9-transport-
ing vesicles were positive for Protrudin (Supplementary Fig. 5a, b)
and 29% of Protrudin-positive endosomes (wild-type or phos-
phomimetic) were also Rab11-positive (Supplementary Fig. 5a, b),
and kymograph analysis demonstrated dynamic co-localization of
both Rab11 and α9-integrin with Protrudin.
To test the contribution of Protrudin’s transport-associated
domains towards its regenerative effects, we assembled a cohort of
Fig. 1 Protrudin is expressed at low levels in mature axons and overexpression restores this deficit. a Schematic diagram of Protrudin’s domains and
structure. b Schematic of wild-type and phosphomimetic Protrudin mutagenesis sites. cmRNA expression levels of six neuronal genes (including Zfyve27—
the Protrudin gene) from different stages of development in primary rat cortical neurons in vitro (n= 5–6 samples). d Normalized expression levels of
Protrudin and other related genes during embryonic development in the mouse (n= 3 animals for each timepoint), after plating DRG neurons in vitro
(n= 3 animals for each timepoint) or after peripheral nerve injury in DRG cells (n= 3 animals for sham and injured samples). e Immunofluorescent images
of Protrudin in the proximal axons (white dotted line box) of neurons at different stages of development in culture. Scale bars are 20 µm. The white arrows
follow the course of the proximal axon. f Immunofluorescent images of overexpressed, mCherry-tagged wild-type or phosphomimetic Protrudin (magenta)
and staining for the axon initial segment marker—neurofascin (cyan). Scale bars are 20 µm. g The axon-to-dendrite ratio of Protrudin at different
developmental stages or after overexpression at 14–16 DIV (n= 4 independent experiments for each condition, n numbers on graph show the number of
analysed cells) (Kruskal–Wallis with Dunn’s multiple comparison test, p < 0.0001, Kruskal–Wallis statistic= 101.6). Error bars represent mean ± SEM.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-19436-y
4 NATURE COMMUNICATIONS |         (2020) 11:5614 | https://doi.org/10.1038/s41467-020-19436-y | www.nature.com/naturecommunications
mutants in accordance with previous literature21,25,27. We deleted
the Rab-binding domain (RBD) which is required for Rab11
anterograde transport21. We also created a mutant which lacked the
FFAT (important for VAPA binding at ER contact sites) and the
coiled-coil domain which has previously been shown to disrupt the
interaction of Protrudin with the anterograde axonal motor KIF527.
We termed this mutant KIF5/VAPA mutant. In addition, we made
a dominant-negative FYVE domain mutant which prevents the
interaction of Protrudin with phosphoinositides on endosomal
membranes25 (Fig. 3e). Each of these mutants was separately
expressed in cortical neurons at 10 DIV and their effects on the
regeneration of mature axons were quantified at 13–17 DIV using
laser axotomy. Unexpectedly, overexpression of the RBD mutant
caused extensive neuronal cell death (Supplementary Fig. 5c, d),
indicating an essential role for the Protrudin-Rab11 interaction in
neuronal viability but precluding examination of its effect on axon
regeneration. Mutations of the KIF5/VAPA or the FYVE domains
sharply diminished the effects of Protrudin overexpression on axon
regeneration, whilst phosphomimetic Protrudin again stimulated
robust regeneration (Fig. 3f). These data demonstrate that the
interactions between Protrudin, endosomes and KIF5 are required
for the axon regeneration-promoting effects of Protrudin, and that
Protrudin-driven regeneration is accompanied by an increase in the
anterograde transport of integrins and Rab11 endosomes.
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Protrudin promotes regeneration through interaction with the
ER. There is increasing evidence that endosomal transport is
heavily influenced by ER-endosome contact sites, and that the
distribution and morphology of ER tubules is controlled by
kinesin-dependent endosomal transport22,30. In addition, ER-
endosome and ER-plasma membrane contact sites have been
observed in both axons and dendrites31. We reasoned that the
localization of Protrudin to the ER, and its interaction with
contact site proteins might contribute to its regenerative effects.
In order to study this, we mutated the FFAT domain which is
important for Protrudin’s interaction with VAP proteins at ER
contact sites23, and we created a mutant lacking all three trans-
membranes (TM1-3) domains which confer its membrane loca-
lization within the ER (Fig. 4a). The deletion of these
hydrophobic regions releases Protrudin from the ER, rendering it
cytosolic23.
The ER exists as a continuous tubular organelle through axons
(similar to an axon within the axon), and its genetic disruption
causes axonal degeneration32. Re-establishment of the axonal ER
may be equally as important as the re-establishment of the axon
membrane for successful regeneration. Because ER tubules
undergo highly dynamic movements, partly by hitchhiking on
motile endosomes33, we hypothesized that linkage of over-
expressed Protrudin to kinesin might lead to an increase in
tubular ER in the axon. To examine the effects of Protrudin
overexpression on axonal ER we analyzed the distribution of
endogenous reticulon 4 (RTN4) by immunofluorescence, which
reports on ER abundance in axons34 (Fig. 4b). Overexpression of
wild-type and phosphomimetic Protrudin resulted in increased
RTN4 in the growth cone shaft and at the axon tip of uninjured
axons with a trend of having more ER in neurons expressing
phosphomimetic Protrudin compared to those with wild-type
Protrudin. Neurons expressing either the FFAT deletion mutant
or the ER-membrane deletion mutant of Protrudin (lacking TM1-
3 domains) did not exhibit an accumulation of RTN4 in the distal
axon (Fig. 4b–d). We observed a similar accumulation of ER at
the tip of protrusions in HeLa cells expressing phosphomimetic
but not wild-type Protrudin (Supplementary Fig. 1d). To confirm
our neuronal findings, we studied the distribution of an
additional smooth ER marker—REEP5 (Supplementary Fig. 6).
We found an accumulation of overexpressed REEP5 at the
growth cone in neurons expressing wild-type and phosphomi-
metic Protrudin with phosphomimetic Protrudin having the most
robust effects (Supplementary Fig. 6). These findings indicate that
phosphomimetic, active Protrudin has stronger effects on ER
mobilization compared with wild-type Protrudin, in contrast to
its effects on Rab11 transport (Fig. 3).
In order to study the importance of the Protrudin-ER interaction
for Protrudin-mediated axon regeneration, each of the mutants
described above was separately expressed in primary rat cortical
neurons at 10 DIV and their effects on axon regeneration were
studied at 13–17 DIV using laser axotomy. Both mutants sharply
diminished the effects of Protrudin overexpression on axon
regeneration compared to phosphomimetic Protrudin which
stimulated robust regeneration (Fig. 4e). However, both deletion
mutants had moderate regenerative effects compared to control
neurons. Whilst these were not statistically significant, they indicate
that Protrudin may exert some effects independently of its
localization to ER contact sites.
We showed above that a combined KIF5/VAPA mutant which
disrupts binding to KIF5 reduced the regenerative effect of
phosphomimetic Protrudin (Fig. 3f). Interestingly, disruption of
the FFAT domain alone had a similar effect on suppressing axon
regeneration to the combined KIF5/VAPA deletion mutant,
underlying the importance of Protrudin’s interaction with ER
contact site protein VAPA to mediate axon regeneration. These
data demonstrate that Protrudin enables the enrichment of ER in
axon growth cones, and that this supports Protrudin’s regen-
erative effects. This indicates an important role for the ER in
mediating CNS axon regeneration.
Collectively, the results so far demonstrate that Protrudin enables
axon regeneration by acting as a scaffold that links key players that
participate in regeneration. Axonal ER, recycling endosomes,
kinesin 1, and phosphoinositides, are all brought together in distal
axons and regenerating growth cones. The finding that mutation of
any of the binding domains in Protrudin abrogates its effect on
regeneration suggests that the co-location of all these components is
necessary for efficient axon regeneration.
Overexpression of Protrudin promotes neuronal survival in the
retina and axon regeneration in the injured optic nerve. Pro-
trudin’s robust effect on CNS axon regeneration in vitro
prompted us to investigate its effectiveness on optic nerve
regeneration. We first examined Protrudin mRNA levels in RGCs
in published RNA-sequencing datasets35 and found that Pro-
trudin mRNA is present at low levels in mature, adult RGCs
(Fig. 5a). This corresponded with our findings in cortical neurons
but not in regenerative PNS neurons where Protrudin levels are
much higher (Fig. 1c, d). We generated three constructs for AAV
delivery to the retina by intravitreal injection: AAV2-GFP,
AAV2-ProtrudinGFP, and AAV2-phosphomimetic-Protrudin-
GFP. The viruses transduced 40–45% of RGCs throughout the
retina and the protein was observed throughout uninjured axons
(Supplementary Fig. 7a, b). Higher Protrudin levels were detected
by immunohistochemistry of wholemount retinas in eyes fol-
lowing overexpression of wild-type or phosphomimetic Protrudin
compared to the control virus (Supplementary Fig. 7c). Viruses
were injected 2 weeks before optic nerve crush, and 2 weeks after
Fig. 2 Protrudin overexpression has a modest effect on initial neurite outgrowth but is a strong promoter of axon regeneration after laser axotomy.
a Example neurons at 4 DIV overexpressing control construct, wild-type or phosphomimetic Protrudin. b The average length of the longest neurite in each
condition (n= 3 independent experiments; 117 control, 102 WT and 109 phosphomimetic Protrudin cells were analysed, p= 0.006, Kruskal–Wallis
with Dunn’s multiple comparison test, Kruskal–Wallis statistic= 10.34). Error bars represent mean ± SEM. c Diagram of the laser axotomy method.
d Representative images show a regenerating and a non-regenerating axon over 14 h post laser axotomy. The red arrows at 0 h post injury shows the point
of injury. The white arrows trace the path of a regenerating axon. Scale bars are 50 µm. e Percentage of regenerating axons overexpressing either mCherry
control (n= 3 independent experiments, 45 neurons), mCherry wild-type Protrudin (n= 3 independent experiments, 45 neurons) or mCherry
phosphomimetic Protrudin (n= 3 independent experiments, 39 neurons) (Fisher’s exact test with analysis of stack of p values and Bonferroni–Dunn
multiple comparison test). Error bars represent mean ± SEM. f Quantification of regeneration distance 14 h after injury of control (n= 9 cells), WT (n= 24
cells) and phosphomimetic Protrudin (n= 21 cells) axons (n= 3 independent experiments, One-way ANOVA, p= 0.04, F statistic= 3.618). Error bars
represent mean ± SEM. g Quantification of regeneration initiation time of control (n= 10 cells), WT (n= 26 cells) and phosphomimetic Protrudin (n= 25
cells) axons (n= 3 independent experiments, One-way ANOVA, p= 0.0004, F statistic= 9.076). Error bars represent mean ± SEM. h Quantification of
the speed of regeneration of control (n= 9 cells), WT (n= 24 cells) and phosphomimetic Protrudin (n= 25 cells) axons (n= 3 independent experiments
One-way ANOVA, p= 0.348, F statistic= 1.078). Error bars represent mean ± SEM.
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injury the anterograde axon tracer—cholera toxin subunit-ß
(CTB) was administered (Fig. 5b). We measured RGC survival in
the retina and axon regeneration in the optic nerve. At 2 weeks
after the injury we quantified RGC survival by counting the
number of RBPMS-positive RGCs in wholemount retinas. We
found that retinas expressing phosphomimetic Protrudin had a
significantly higher percentage of surviving RGCs (52%) com-
pared to those injected with GFP control (28%) whilst trans-
duction with wild-type Protrudin (27%) had no effect (Fig. 5c, d).
In contrast, both wild-type and phosphomimetic Protrudin had
robust effects on axon regeneration. Optic nerves of mice
expressing GFP exhibited limited regeneration (0% >0.5 mm from
fe
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the crush site), while regenerating axons extended up to 2.75 mm
in wild-type Protrudin-transduced animals, and as far as 3.5 mm
in phosphomimetic Protrudin-transduced animals. The numbers
of regenerating axons were high, particularly for phosphomimetic
Protrudin, in which over 630 axons were seen proximally, sig-
nificantly more than in control (44 axons) or in wild-type Pro-
trudin (380 axons) (Fig. 5e, f). Co-localization between CTB and
GAP43 was found throughout the nerve in all conditions sug-
gesting that the majority of CTB-positive axons observed in the
nerve past the injury site are regenerating axons (Supplementary
Fig. 7d). These findings confirm that phosphomimetic Protrudin
expression leads to a substantial increase in neuronal survival and
axon regeneration in the injured CNS, whilst wild-type Protrudin
overexpression does not protect RGCs from death, but has robust
effects on the regeneration of surviving neurons.
Overexpression of wild-type or phosphomimetic Protrudin is
neuroprotective in vivo. We next examined the effects of Pro-
trudin expression using an additional RGC neuroprotection
model. Because optic nerve injury leads to severe neuronal loss
two weeks after injury (typically 80–90%) we used an acute retinal
explant model which is often used to detect potential neuropro-
tective treatments for glaucoma36,37. Viruses were injected
intravitreally, and retinas were removed two weeks later and
cultured as explants for three days (Fig. 6a). Both wild-type and
phosphomimetic Protrudin were entirely neuroprotective, with
these retinas exhibiting no loss of RGC neurons, whilst GFP-only
controls lost 55% of their RGCs (Fig. 6b, c). In addition, both
Protrudin constructs showed widespread general neuroprotection
as there was no reduction in the DAPI-positive cells after injury
(Fig. 6d).
Discussion
Our study demonstrates axon regeneration in the CNS driven by
overexpression of the scaffold molecule, Protrudin. Protrudin
enables robust axon regeneration and neuroprotection in the
retina and optic nerve and promotes regeneration after axotomy
of cortical neurons in vitro. The action of Protrudin is to bind
recycling endosomes, ER and kinesin and carry them and their
contents to the tip of axons and growth cones.
Protrudin mRNA is expressed at low levels in cultured CNS
cortical neurons compared to other abundantly expressed pro-
teins (Fig. 1c). In previous reports, Protrudin has been detected in
mouse primary hippocampal neurons at 1 DIV predominantly
localized to the pericentrosomal compartment and to growing
neurites, and present in dendrites and at the growth cone21. Here,
we examined the distribution of the endogenous protrudin pro-
tein in rat primary cortical cultures throughout development19.
We found that Protrudin’s distribution changes with neuronal
maturity. Protrudin is present in the newly extending axons but
as neurons mature and polarize, the Protrudin protein is redis-
tributed towards the cell body and dendrites, suggesting that the
protein is not available to participate in regeneration (Fig. 1e–g).
Many molecules become selectively excluded from axons and
directed to dendrites as neurons mature and compartmentalize.
Previously we have studied the selective distribution of Rab11 and
integrins which are essential for neurite outgrowth and axon
transport17,19. For these molecules the exclusion from axons is
more complete than for Protrudin which is driven in axons when
the levels in the cell body are raised by overexpression. The
exclusion of growth-related molecules from mature axons is one
of the reasons for their failure to regenerate, and restoration of
Rab11 vesicles and integrins to mature axons can restore
regeneration17,19,38.
The main aims of this study were to determine whether Pro-
trudin can enable axon growth and regeneration and investigate
its mechanism of action. Previously, the ability of Protrudin to
stimulate process outgrowth was shown to be dependent on its
phosphorylation. Because receptors able to activate proteins by
phosphorylation may be sparse in mature CNS axons39, a con-
struct for phosphomimetic, constitutively active Protrudin was
made, based on the previously identified phosphorylation sites21.
Previous reports have shown that overexpression of Protrudin
can enhance neurite outgrowth in PC12 cells and in hippocampal
neurons at early stages of development21. Overexpression of
Protrudin during early neurite extension upon dissociation led to
a modest increase in axon length when phosphomimetic Pro-
trudin was overexpressed in rat cortical neurons (Fig. 2a, b).
However, we did not observe any differences when wild-type
Protrudin was overexpressed, as predicted by previous studies in
hippocampal neurons21.
To measure the effects of Protrudin on axon regeneration we
used a culture model in which neurons mature over time, and the
probability of axons regenerating declines from around 70 to 5%
by 20 DIV19. These in vitro regeneration experiments demonstrate
that wild-type and phosphomimetic Protrudin greatly enhance
axon regeneration after laser injury (Fig. 2c–h). The percentage of
regenerating axons especially in the phosphomimetic Protrudin
condition (70%) was found to be higher than some of the best
treatments utilised previously in this model system such as
depletion of EFA6—an ARF6 activator in the axon (59%)18 and
Fig. 3 Protrudin enhances the transport of growth machinery and receptors in the distal axon, and its involvement in axon transport is required for
axon regeneration. a Representative distal axon sections of neurons expressing integrin α9-GFP or Rab11-GFP, together with either mCherry (control),
mCherry-wild-type Protrudin or mCherry-phosphomimetic Protrudin. Scale bar is 20 µm. b Kymographs showing the dynamics of integrin α9-GFP
and Rab11-GFP in distal axons of co-transfected neurons. Scale bar is 10 µm. c Quantification of Rab11-GFP axon vesicle dynamics and total number
of Rab11 GFP vesicles in distal axon sections (n= 3 independent experiments) (for transport, Kruskal–Wallis with Dunn’s multiple comparison test
was used; anterograde—p= 0.175, Kruskal–Wallis statistic= 3.489; retrograde—p= 0.02, Kruskal–Wallis statistic= 8.197, bidirectional—p= 0.0002,
Kruskal–Wallis statistic= 16.60, static—p= 0.105, Kruskal–Wallis statistic= 4.499; for total number of vesicles, one-way ANOVA was used—p < 0.0001,
F statistic= 15.68). Error bars represent mean ± SEM. d Quantification of integrin α9-GFP axon vesicle dynamics and total number of integrin α9-GFP
vesicles in distal axon sections (n= 3 independent experiments) (for transport, Kruskal–Wallis with Dunn’s multiple comparison test was used;
anterograde—p= 0.002, Kruskal–Wallis statistic= 12.57; retrograde—p= 0.0003, Kruskal–Wallis statistic= 16.64, bidirectional—p= 0.271, Kruskal–
Wallis statistic= 2.610, static—p= 0.051, Kruskal–Wallis statistic= 5.951; for total number of vesicles—p < 0.0001, Kruskal–Wallis statistic= 21.81). Error
bars represent mean ± SEM. e Schematic representation of Protrudin transport domain mutants. f Percentage of regenerating axons in neurons expressing
mCherry-Protrudin domain mutants—FYVE (n= 4 independent experiments, 56 neurons) and KIF5/VAPA (n= 4 independent experiments, 56 neurons)
compared to phospho-Protrudin as a positive control (n= 2 independent experiments, 24 neurons), and mCherry as a negative control (n= 3 independent
experiments, 42 neurons) (Fisher’s exact test with analysis of stack of p values and Bonferroni–Dunn multiple comparison test). Error bars represent
mean ± SEM.
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overexpression of dominant-negative Rab11 (38%)19. Seventy
percent appears to be the ceiling value for regeneration in this
assay. Overexpression of wild-type Protrudin was also capable of
enhancing axon regeneration but to a lesser extent than phos-
phomimetic Protrudin.
Once Protrudin’s regenerative ability was confirmed, we studied
potential mechanisms, based on Protrudin’s many interaction
domains. Protrudin’s actions affected transport as predicted, because
overexpression of wild-type and phosphorylated Protrudin resulted
in increased transport of Rab11 endosomes and in enhanced ante-
rograde and retrograde transport of integrins in the distal axon
(Fig. 3a–d). This study focused on integrin α9 because of its ability
to promote long-range axon regeneration in the spinal cord and on
Rab11 because these endosomes transport integrins15,17; however,
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Fig. 4 Protrudin overexpression enhances ER presence at growth cones and this interaction is required for successful axon regeneration. a Schematic
representation of Protrudin endoplasmic reticulum domain mutants. b Representative images of RTN4 immunofluorescence (green) in the distal axon of
neurons expressing the indicated m-Cherry Protrudin constructs (magenta). Scale bar is 10 μm. c, d Quantification of RTN4 fluorescence intensity at the
axon tip and shaft (p < 0.0001, Kruskal–Wallis with Dunn’s multiple comparisons test). Error bars represent mean ± SEM. e Percentage of regenerating
axons in neurons expressing mCherry-Protrudin domain mutants—FFAT (n= 4 independent experiments, 60 neurons) and TM1-3 (n= 5 independent
experiments, 45 neurons) compared to phosphomimetic Protrudin as a positive control (n= 2 independent experiments, 21 neurons), and mCherry as a
negative control (n= 3 independent experiments, 41 neurons). Error bars represent mean ± SEM.
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the effects of Protrudin on axon growth are most likely both integrin
dependent and independent29. In addition to integrins, Rab11
endosomes transport many growth-promoting molecules that could
influence regeneration including the IGF-1 and TrkB receptors40–42.
Rab11 may also promote regeneration through regulation of
membrane trafficking events43. In addition, based on the original
hypothesis, the domain’s linking axonal transport to membrane and
endosomal trafficking (FYVE domain, KIF5/VAPA domain and
RBD) were mutated, and each of these changes suppressed the axon
regeneration-promoting effect of Protrudin (Fig. 3e, f).
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The involvement of the ER in axon regeneration has not been
extensively studied in mammalian CNS neurons before. One
previous study has presented correlative evidence implicating not
only the ER but also the protrudin-binding protein—spastin in
axon but not dendrite regeneration due to their accumulation at
the tips of regenerating axons after axonal injury in Drosophila44
and ER-microtubule interaction is involved in the establishment
of neuronal polarity34. Here, we found that phosphomimetic
Protrudin overexpression increased ER (shown by RTN4 and
REEP5, markers of smooth ER)34 in axonal growth-cones
(Fig. 4b–d). In addition, TM1-3 deletion mutant and FFAT
deletion mutant Protrudin, both important for ER localization,
each eliminated its ability to enrich ER at growth cones to the
same extent as wild-type or phosphomimetic Protrudin and to
promote axon regeneration after laser axotomy (Fig. 4). There are
several mechanisms by which enrichment of the ER could facil-
itate axon regeneration, including bulk transfer of lipids from the
ER to the plasma membrane, synthesis and transfer of signalling
lipids, calcium signalling and involvement in organelle trafficking.
ER-plasma membrane interaction sites are a potential site for
some of these interactions22,45. Protrudin-mediated enrichment
of ER into the tip of growing processes could function to enable
the transfer of lipids, with the FYVE domain promoting inter-
action with the surface membrane25, allowing for rapid expansion
of the growth cone plasma membrane—a requirement for suc-
cessful axon regeneration46.
The overall result of these studies into the interaction domains
of Protrudin is that all of them are involved in axon regeneration,
and that inactivation of any of them removes most of the ability
of Protrudin to promote regeneration. The conclusion is that
Protrudin works by bringing all of its binding partners together in
such a way that they can collaborate in enabling axon regenera-
tion. An outstanding issue is the relative contribution of the ER
and Rab11 to the regenerative effects of Protrudin and phos-
phomimetic Protrudin, especially because the ER is closely linked
to numerous types of endosomes through interactions at contact
sites. Further work is needed to determine if additional inter-
ventions which increase axonal ER also lead to enhanced regen-
eration, independently of a direct interaction with Rab11.
The next step was to examine Protrudin’s effects in vivo. The
optic nerve crush model has proven an excellent screen for
regeneration treatments. Promoting RGC regeneration has the
potential to restore vision loss associated with optic neuropathies
such as glaucoma, and virally delivered gene therapy for eye
disease is already in clinical practice47. In the current study, adult
mice were treated by delivering an AAV vector into the vitreous
2 weeks before an optic nerve crush. Both phosphomimetic and
wild-type Protrudin led to a large number of axons regenerating
for a long distance only 2 weeks after optic nerve crush with only
phosphomimetic Protrudin having a pronounced effect on
neuronal survival 2 weeks post crush (Fig. 5). Expression of
phosphomimetic Protrudin allowed for 400–500 neuronal fibres
to reach the 0.5 mm mark by 2 weeks after injury suggesting that
this intervention is comparable to the most potent interventions
reported to date.
In addition, Protrudin’s overexpression (both wild-type and
phosphomimetic forms) was completely neuroprotective in a
retinal explant model of RGC injury and 2 weeks post optic nerve
crush (Figs. 5, 6). This effect could be due to increased signalling
as a result of improved axonal transport which in turn activates
retrograde survival signals. Further studies are needed in order to
pinpoint the exact mechanism of Protrudin-driven neuroprotec-
tion in the eye.
Our study demonstrates robust axon regeneration in the adult
CNS driven by overexpression of the adapter protein Protrudin.
Overexpression of Protrudin, particularly in its phosphomimetic,
active form greatly enhanced regeneration in cortical neurons
in vitro and in the injured adult optic nerve. Importantly, both
wild-type Protrudin and phosphomimetic Protrudin expression
lead to an accumulation of ER and enhanced axonal transport in
the distal axon and interfering with Protrudin’s ER localization or
transport domains abrogates its regenerative effects, indicating a
central role for these processes in mediating Protrudin-driven
regeneration. We propose that Protrudin enables regeneration by
acting as a scaffold to link the ER, recycling endosomes, kinesin-
based transport and membrane phospholipids. Our findings
establish the importance of these components in facilitating CNS
axon regeneration, whilst suggesting Protrudin gene-therapy as a
potential approach for repairing CNS axon damage.
Methods
DNA constructs. Human Protrudin constructs (in pmCherry-C1 and pEGFP-C1)48,
CMV-integrin-alpha9-GFP29 and CMV-Rab11 -GFP19,29 were used. The CMV
promoter in all constructs was replaced by a human synapsin (Syn) promoter by
Gibson assembly cloning. The viral vector plasmid backbones (AAV2-sCAG-GFP)
were a kind donation by Prof. Joost Verhaagen, The Netherlands Institute for
Neuroscience. Protrudin-GFP was cloned from pEGFP-C1 plasmid into viral vector
plasmids using Gibson cloning. Site-direct mutagenesis was performed in order to
create the Protrudin active phosphomimetic form (QuikChange II Site-Directed
Mutagenesis Kit, Agilent Technologies). All primers used for Protrudin cloning are
described in Table S1. All constructs were verified by DNA sequencing.
Cell culture and transfections. Rat cortical neurons were dissected from E18
embryos from Sprague Dawley rats and plated on imaging dishes or on acid-
washed glass coverslips at the following densities: 1 × 105 cells/dish for immuno-
cytochemistry, 2 × 105 for axotomy or live-cell imaging and 8 × 104 cells/coverslip.
All surfaces were coated with poly-D-lysine (Sigma, D1149-100MG), diluted in
borate buffer to a final concentration 50 μg/mL. The cells were grown in serum-free
MACS Neurobasal Media supplemented with 2% NeuroBrew21 and 1% GlutaMAX
supplements at 37 °C in 7% CO2 incubator. Cortical neurons were transfected using
NeuroMag magnetofection (Oz Biosciences, NM50200) system where 7 μg of DNA
plasmid is mixed with 100 μL NB media and 8 μL of magnetic beads. The reaction
was kept for 30 min at 37 °C before adding 900 μL of pre-warmed NB media to a
final volume of 1 mL. The original neuronal media was removed, and 1 mL of
Fig. 5 Protrudin enhances regeneration of RGC axons following optic nerve crush. a Protrudin mRNA levels during the progression of glaucoma in
comparison to other neuronal markers. b Experimental timeline for optic nerve crush. c Representative images of retinal wholemounts stained for RBPMS
(white) to label retinal ganglion cells in the uninjured and injured for each condition 2 weeks after optic nerve crush. Scale bars are 100 µm. d Quantification
of RGC survival 2 weeks post crush. Eyes injected with phosphomimetic Protrudin have a higher percentage of RGC survival (n= 5 animals) compared
to control (n= 7 animals, p= 0.007) or wild-type Protrudin (n= 7 animals, p= 0.002) (Fisher’s exact test with analysis of stack of p values and
Bonferroni–Dunn multiple comparison test). Error bars represent mean ± SEM. e CTB-labelled axons in the optic nerves of mice transduced with viruses for
wild-type Protrudin, phosphomimetic Protrudin and GFP control. Arrows indicate lesion site. Insets (iv-vi) show regenerating axons in the distal optic nerve.
Scale bar is 200 μm and on inset is 20 μm (n= 8–9 animals/group). f Quantification of regenerating axons at increasing distances distal to the lesion site,
displayed as mean ± SEM. Statistical significance was determined by two-way ANOVA with Bonferroni post hoc test for multiple comparisons. **p < 0.005,
***p < 0.001, ****p < 0.0001. Individual p values are as follows: p < 0.0001 for GFP vs. WT and GFP vs. phosphomimetic Protrudin at 0.25mm, p= 0.003
for WT vs. phosphomimetic Protrudin at 0.25 mm, p= 0.01 for GFP vs. WT at 0.5 mm, p < 0.001 for GFP vs. phosphomimetic Protrudin at 0.5 mm,
p= 0.02 for WT vs. phosphomimetic Protrudin at 0.5 mm and p= 0.01 for GFP vs. phosphomimetic Protrudin at 0.75 mm. The box plots show the
first and third quartiles (the box limits), the median (horizontal line), and the minimum and maximum values (whiskers).
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transfection mixture was added. Dishes were then incubated at 37 °C for 30 min on
a magnetic plate before the original media was returned on the plates. Plasmid
reporter gene expression was observed 48 h post-transfection.
Antibodies. Rabbit anti-Zfyve27 (Proteintech, 12680-1-AP, 1:500), Mouse Pan-
Neurofascin (extracellular) (NeuroMab, 75–172, 1:50), Rabbit anti-Reticulon 4
(Novus Biologicals, NB100-56681, 1:250), Rabbit anti-RBPMS (Phosphosolutions,
1830-RBPMS, 1:500), Mouse anti-mCherry (ClonTech, 632543, 1:500), DAPI
(ThermoFisher Scientific, D3751, 1:10,000), Sheep anti-GAP43 (kind donation
from the Benowitz lab, 1:5000), mouse monoclonal anti-beta actin (C4) HRP
conjugated (Santa Cruz, sc-47778, 1:5000), goat anti-rabbit IgG HRP conjugated
(Sigma, A4914, 1:80000),Goat anti-rabbit 488 (ThermoFisher Scientific, A27034,
1:500), Goat anti-rabbit 568 (ThermoFisher Scientific, A-11011, 1:500), Goat anti-
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Fig. 6 Protrudin is neuroprotective to RGCs and other cell types in the retina after a retinal explant. a Experimental timeline for retinal explant
experiment. b Representative images of RGCs (red for RBPMS) 0 and 3 days ex vivo (DEV) in eyes injected with control virus, wild-type Protrudin or
phosphomimetic Protrudin (green for GFP) and stained for DAPI (blue). Scale bar is 20 µm. c Quantification of RGC survival in retinal explant (n= 4–6
animals for each condition) (Two-tailed Student’s t-test). **p < 0.005, ***p < 0.001, ****p < 0.0001. Individual p values are as follows: p < 0.0001 for GFP,
p= 0.945 for WT and p= 0.439 for phosphomimetic Protrudin when compared at 0 DEV to 3 DEV. The box plots show the first and third quartiles
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rabbit 647 (ThermoFisher Scientific, A27040, 1:500), Goat anti-mouse 647
(ThermoFisher Scientific, A-21235, 1:500), Goat anti-mouse 568 (ThermoFisher
Scientific, A-11031, 1:500).
Immunostaining. Cortical neurons were fixed in 3% PFA for 15 min and then
thoroughly washed and kept in PBS at 4 °C. Cells were permeabilized in 3% BSA in
PBS and 0.1% Triton for 5 min and then blocking solution was added (3% BSA in
PBS) for 1 h at room temperature. Primary antibodies were added at the correct
concentration and kept for 1.5 h at room temperature. Antibodies were then
washed three times in PBS for 5 min. Secondary antibodies were applied at the
correct concentration for 1 h at room temperature in a dark chamber. The cells
were then washed three times in 1xPBS and mounted using coverslips and Dia-
mond anti-fade mounting agent with DAPI (Molecular Probes) or FluorSave
mounting reagent (Calbiochem). Mice were anesthetized using 1–2% isoflurane
and transcardially perfused with PBS followed by 4% paraformaldehyde (PFA).
Optic nerves were dissected and immersed in 4% PFA. The tissue was post-fixed
overnight, then immersed in 30% sucrose for 24 h for cryoprotection. Tissue was
embedded in Tissue-Tek OCT and snap-frozen for cryosectioning. 14-μm-thick
longitudinal sections of the optic nerve were obtained on charged Superfrost
microscope slides using a Leica CM3050 cryostat. Slides were dried and stored at
−20 °C.
Confocal microscopy. Images of immunostained cells were taken with a confocal
microscope (Leica DMI 4000 B) using LAS-AF software (Leica, Version
2.7.3.9723). For Protrudin localisation, a z-stack of images was obtained through
each cell by taking an image at every 0.5-μm thickness and an average intensity z-
projection was created in Fiji software49. All images in an experiment were taken
using the same microscope settings. The intensity of processes was measured by
placing a line shape (usually about 50 μm) on processes and taking a background
intensity of the same shape immediately next to each process. The background was
then subtracted from the intensity at each process. For Protrudin intensity mea-
surements in GFP-transfected neurons, regions of interest were selected in the 488
channel and a line was placed on each process and immediately next to it to
measure background. This strategy immediately excludes any biases on selecting
processes with higher intensity of protrudin staining. For all experiments mea-
suring axon-to-dendrite ratio, the intensity in dendrites was an average from
measurements in at least 3 dendrites per cell where possible.
Live-cell imaging. Live-cell imaging was performed using spinning disk confocal
microscopy, using an Olympus IX70 microscope with a Hamamatsu EM-CCD
Image-EM camera and a PerkinElmer Ultra-VIEW scanner. Videos were taken
using Meta-Morph software (Version 7.6.1.0). Rab11 and integrin vesicle traf-
ficking along the axon was imaged at the proximal (up to 100 μm) and distal part
(beyond 600 μm) of axons of neurons transfected with Protrudin (as described
before in18,29). In short, one image per second was obtained for 3 min. Kymographs
were obtained by measuring an individual axon segment. Anterograde, retrograde,
bidirectional and static modes of transport were measured. The percentage of co-
localization between integrin or rab11 and Protrudin was calculated as the number
of vesicles containing either was divided by the total number of vesicles. All ana-
lysis was performed using Meta-Morph software (Version 7.6.1.0).
Western blotting. PC12 cells were transfected using lipofectamine. Forty-eight
hours later cells were lysed using the cOmplete Lysis Kit (Roche). Cells were
washed with ice-cold PBS. Five-hundred microliters of pre-cooled lysis buffer was
added to each well of a 6-well plate and the lysate was scraped using a cell scraper
and transferred to a sterile 1.5 mL Eppendorf. The lysate was incubated on ice for
30 min with occasional mixing. The samples were then centrifuged at 10,000 × g at
4 °C for 10 min. The supernatant was transferred to 1.5 mL Eppendorf and the
pellet was discarded. The total protein concentration was measure by BCA assay
using Pierce BCA Assay Kit Protocol (ThermoFischer Scientific). The 96-well plate
containing the sample lysates and BCA reagents was analyzed using
Gen5.1 software and concentrations were derived from a standard curve for
albumin control. 15 μg of PC12 cell lysate was then treated with LDS Sample Buffer
NuPAGE 4x (1:4, ThermoFisher Scientific) and Sample Reducing Agent (1:10,
ThermoFisher Scientific) and were analyzed by Western blot. Samples were run on
a 4–12% gel at 120 V at room temperature in 40 mL Running Buffer NuPAGE
(ThermoFisher Scientific) diluted in H20 to 800 mL. The gel was then transferred
onto a nitrocellulose membrane (Invitrolon PDVF/Filter Paper Sandwich, Ther-
moFischer Scientific) for 1.5 h at 40 V at 4 °C in 50 mL Transfer Buffer NuPAGE
(ThermoFisher Scientific) in 100 mL methanol, topped up with ddH20 to 1 L. The
membrane was then blocked either in 5% milk or 3% BSA depending on the
antibody for 1 h and incubated overnight with the primary antibody diluted the
blocking solution to the right concentration at 4 °C. The membrane was then
rinsed three times in Tris-buffered saline with Tween 20 (TBST buffer) for 10 min
each. The TBST buffer was removed. Secondary peroxidase-conjugated antibodies
were diluted to the right concentration in blocking solution and were then added
for 1 h at room temperature. SuperSignal West Dura Extended Duration Substrate
kit (ThermoFischer Scientific) and Alliance software (Version 16.05) were then
used for detection.
Axotomy. 10 DIV neurons were transfected with various constructs using mag-
netofection as described above. Between 13–17 DIV, their regeneration ability was
examined using the laser axotomy model described in detail in19. In short, axotomy
was performed by an UV Laser (355 nm, DPSL-355/14, Rapp OptoElectronic,
Germany) connected to a Leica DMI6000B (Leica Systems, Germany), and all
images were taken with an EMCCD camera (C9100-02, Hamamatsu). Axons were
cut at least 600 μm away from the cell body and regeneration was observed for 14 h
post injury at 30-min intervals. If more than 50% neuronal cell death occurred in
the axotomised cells, the experiment was excluded from the final analysis.
Animal studies. All procedures were performed in accordance with protocols
approved by the Institutional Animal Care and Use Committee (IACUC) at the
National Institutes of Health, by the UK Home Office regulations for the care and
use of laboratory animals under the UK Animals (Scientific Procedures) Act (1986)
and in accordance with the Swedish Board of Agriculture guidelines and were
approved by the Karolinska Institutet Animal Care Committee. Pregnant female
Sprague Dawley rats (Charles River, 8–12 weeks old) were housed in pathogen-free
facility with free access to food and a standard 12-h light/dark cycle and embryos of
both sexes were dissected at E18 for cortical cultures. Female C57Bl/6 mice aged
6–8 weeks (Charles River) were housed in a pathogen-free facility with free access
to food and a standard 12-h light/dark cycle. All animals were housed at 18–23 °C
and in 40–60% humidity. Intravitreal injections of viruses were administered
14 days prior to optic nerve crush or whole retinal explant. Two microliters of the
injecting solution for mice was drawn into a sterile 5 μL Hamilton syringe (#65RN;
Needle: ga33, 8 mm, pst2, Hamilton Co.). Attention was paid to avoid lens pene-
tration, extraocular muscles and vortex vein impingement. The Hamilton syringe
was then held in situ for 30 s before a sterile 30-gauge needle (B. Braun Medical
Ltd.) was used to puncture the central cornea, reducing intraocular pressure and
injection solution reflux, at which point the Hamilton syringe was carefully
withdrawn. Separate needles were allocated to each virus to prevent contamination,
and syringes were rinsed between injections with ethanol followed by sterile PBS.
Optic nerve crush. Optic nerve crush was performed as described previously50 and
as follows: Micro-scissors were used to make an incision in the conjunctiva and
expose the optic nerve. Curved forceps were then inserted below the external ocular
muscle, avoiding the ophthalmic artery and retrobulbar sinus, and positioned
around the exposed nerve. The nerve was crushed for 10 s ~1 mm posterior to the
eye. Eyes were then observed fundoscopically for signs of ischaemia, and mice were
monitored for signs of intraorbital bleeding. Mice were given a subcutaneous
injection of 1 mg/kg buprenorphrine as an analgesic and topical application of
ophthalmic ointment to prevent corneal drying. Intravitreal injections of CTB
(1.0 μg/μL, Sigma) were administered 2 days prior to perfusion. 2 μL of the solution
injected as described above. Images of optic nerves and retinas were obtained using
the ZEN Digital Imaging Suite.
Retinal wholemounts preparations. Eyes were sharp dissected out of the orbit
with Vanna scissors and immediately immersed in 4% PFA for 2 h before transfer
to PBS. Retinal wholemounts were then prepared under a dissection microscope,
flat mounted onto Milipore filter paper in 24-well plates and stored at 4 °C. Fol-
lowing three 10-min washes with PBS, TBST blocking buffer (3% goat serum, 1%
BSA, 0.3% TritonX-100) was applied for 1 h at room temperature with gentle
rotation. This was replaced with RBPMS primary antibody (Phosphosolutions,
Aurora, USA; 1:500) in TBST blocking buffer at 4 °C overnight with gentle rota-
tion. Following three further 10-min washes with PBS, Alexa Fluor 647 secondary
antibody 1:500 in TBST blocking buffer at 4 °C overnight with gentle rotation.
After three further washes with PBS, mounted onto charged Superfrost microslides
using Fluorsave mounting reagent (Calbiochem) and allowed to dry for 4 h before
imaging. Blinded manual counting of all images was undertaken (8 images/
wholemount, 2 images/quadrant). Uninjured right eyes were counted (n= 3–4 per
group) and the averaged used to normalize percentage RGC survival.
Whole retina explant culture. Mice were euthanized by cervical dislocation, eyes
enucleated, and placed immediately into ice-cold HBSS. Retinas were dissected
from the eyes in HBSS on ice, flat-mounted with the ganglion cell layer up on a cell
culture insert (Millipore), and submerged in tissue culture media containing
Neurobasal –A, 1% penicillin-streptomycin (10,000 U/ml), 1% glutamine (100×),
1% N-2 (100×) and 1% B-27 (50×) (all ThermoFisher Scientific). Retinas were
incubated in 6-well plates at 37 °C and 4% CO2 for 3 days and were fed by
replacing 50% of the media on day 2. Retina were fixed in 3.7% PFA and stained
with antibodies against RBMPS and GFP followed by counterstaining with DAPI.
For untreated “DEV 0” controls, retinas were dissected and placed straight into
3.7% PFA.
Statistics and reproducibility. Statistical analysis was performed using GraphPad
Prism 8.0 (GraphPad Software, La Jolla, CA). Each data set was individually tested
for normal distribution using the D’Agostino–Pearson normality test. When data
were normally distributed one-way ANOVA with multiple comparisons was used
to test statistical significance between the experimental groups with Tukey’s post
hoc test. Several data sets were shown to be non-normally distributed. Therefore, a
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non-parametric Kruskal–Wallis test with multiple comparisons was used to test for
significant differences across experimental groups. Dunn’s multiple comparison
post hoc test was also performed. All statistics were carried out at 95% confidence
intervals, therefore a significant threshold of p < 0.05 was used in all analyses. For
Sholl analysis, repeated measures two-way ANOVA was performed using SPSS
(Version 26, IBM Statistics). When comparing percentages (e.g. of regenerating
cells or RGC survival after optic nerve crush), Fisher’s exact test was performed
between each two groups compared. p-values were then analyzed with the “Analyze
a stack of p values” function in GraphPad Prism with a Bonferroni–Dunn pairwise
comparison to test for statistical significance between groups. All representative
images, kymographs or micrographs were obtained from experiments which were
repeated at least three times.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The RNA-sequencing datasets from peripheral DRG neurons in development and after
injury28, from RGCs during development35 or from cultured rat primary cortical
neurons19 used for analysis in this study (Fig. 1c, d) have previously been published and
deposited in NCBI Gene Expression Omnibus (accession numbers: GSE66128, GSE90654
and GSE92856, respectively). The rest of the data generated to support the findings of
this study are available from the corresponding author upon reasonable request. Source
data are provided with this paper.
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